IRadimed Corporation
General ticker "IRMD" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $769.2M (TTM average)
IRadimed Corporation follows the US Stock Market performance with the rate: 60.9%.
Estimated limits based on current volatility of 1.3%: low 92.30$, high 94.79$
Factors to consider:
- Company pays dividends (quarterly): last record date 2025-11-14, amount 0.17$ (Y0.72%)
- Total employees count: 160 (+8.1%) as of 2024
- Top business risk factors: Dependence on limited products, Supply chain disruptions, Cybersecurity threats, Regulatory and compliance, Market competition
- Current price 40.4% above estimated high
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [44.58$, 66.89$]
- 2025-12-31 to 2026-12-31 estimated range: [46.65$, 70.10$]
Financial Metrics affecting the IRMD estimates:
- Negative: with PPE of 32.9 at the end of fiscal year the price was very high
- Positive: Operating profit margin, % of 29.99 > 18.64
- Positive: Return on assets ratio (scaled to [-100,100]) of 16.36 > 6.04
- Positive: Inventory ratio change, % of -3.52 <= -0.75
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Positive: Shareholder equity ratio, % of 88.30 > 63.39
- Positive: 0.33 < Operating cash flow per share per price, % of 3.73
- Positive: -4.48 < Investing cash flow per share per price, % of -1.28
Short-term IRMD quotes
Long-term IRMD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $53.30MM | $65.56MM | $73.24MM |
| Operating Expenses | $37.68MM | $45.53MM | $51.28MM |
| Operating Income | $15.63MM | $20.04MM | $21.96MM |
| Non-Operating Income | $0.55MM | $1.70MM | $2.31MM |
| R&D Expense | $2.28MM | $2.86MM | $2.83MM |
| Income(Loss) | $16.18MM | $21.74MM | $24.28MM |
| Taxes | $3.35MM | $4.55MM | $5.04MM |
| Profit(Loss)* | $12.83MM | $17.19MM | $19.23MM |
| Stockholders Equity | $73.67MM | $71.42MM | $86.82MM |
| Inventory | $5.37MM | $12.82MM | $10.40MM |
| Assets | $85.51MM | $92.16MM | $98.33MM |
| Operating Cash Flow | $10.04MM | $13.47MM | $25.62MM |
| Capital expenditure | $1.87MM | $8.01MM | $8.01MM |
| Investing Cash Flow | $-1.37MM | $-8.01MM | $-8.82MM |
| Financing Cash Flow | $-12.71MM | $-13.66MM | $-14.34MM |
| Earnings Per Share** | $1.02 | $1.36 | $1.52 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.